These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33341811)

  • 1. Potential Role of Hypothalamic and Plasma Ghrelin in the Feeding Behavior of Obese Type 2 Diabetic Rats with Intraventricular Glucagon-Like Peptide-1 Receptor Agonist Intervention.
    Lu K; Chen X; Deng X; Long J; Yan J
    Obes Facts; 2021; 14(1):10-20. PubMed ID: 33341811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Feeding Behavior on Hypothalamus in Obese Type 2 Diabetic Rats with Glucagon-like Peptide-1 Receptor Agonist Intervention.
    Lu K; Chen X; Yan J; Li X; Huang C; Wan Q; Deng X; Zou Q
    Obes Facts; 2018; 11(3):181-194. PubMed ID: 29788009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 decreases ghrelin levels through mTOR signaling.
    Hong X; Zhang H; Liang H; Li D; Huang J; Li Z; Jiang S; Zhang W; Xu G
    Mol Cell Endocrinol; 2016 Dec; 437():201-212. PubMed ID: 27569528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
    Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
    Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster.
    Alves PL; Abdalla FMF; Alponti RF; Silveira PF
    Toxicon; 2017 Sep; 135():1-11. PubMed ID: 28579479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of peripheral administration of exendin-4 on food intake are attenuated by lesions of the central nucleus of amygdala.
    Qiao H; Ren WN; Li HZ; Hou YX
    Brain Res Bull; 2019 May; 148():131-135. PubMed ID: 30862486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?
    Buckley MM; O'Brien R; Buckley JM; O'Malley D
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13684. PubMed ID: 31311066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of short and long exposure to cafeteria diet on food intake and white adipose tissue lipolysis mediated by glucagon-like peptide 1 receptor.
    Mattar P; Jaque C; Teske JA; Morselli E; Kerr B; Cortés V; Baudrand R; Perez-Leighton CE
    Front Endocrinol (Lausanne); 2023; 14():1164047. PubMed ID: 37293487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4 potently decreases ghrelin levels in fasting rats.
    Pérez-Tilve D; González-Matías L; Alvarez-Crespo M; Leiras R; Tovar S; Diéguez C; Mallo F
    Diabetes; 2007 Jan; 56(1):143-51. PubMed ID: 17192476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sleeve gastrectomy and gastric banding on the hypothalamic feeding center in an obese rat model.
    Kawasaki T; Ohta M; Kawano Y; Masuda T; Gotoh K; Inomata M; Kitano S
    Surg Today; 2015 Dec; 45(12):1560-6. PubMed ID: 25724939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic injection of oxyntomodulin suppresses circulating ghrelin-like immunoreactivity.
    Patterson M; Murphy KG; Patel SR; Patel NA; Greenwood HC; Cooke JH; Campbell D; Bewick GA; Ghatei MA; Bloom SR
    Endocrinology; 2009 Aug; 150(8):3513-20. PubMed ID: 19359390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
    Elvert R; Herling AW; Bossart M; Weiss T; Zhang B; Wenski P; Wandschneider J; Kleutsch S; Butty U; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Lorenz M; Keil S; Larsen PJ
    Diabetes Obes Metab; 2018 Aug; 20(8):1836-1851. PubMed ID: 29938884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLP-2 decreases food intake in the dorsomedial hypothalamic nucleus (DMH) through Exendin
    Sun H; Meng K; Hou L; Shang L; Yan J
    Physiol Behav; 2021 Feb; 229():113253. PubMed ID: 33220330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-2 directly regulates hypothalamic neurons expressing neuropeptides linked to appetite control in vivo and in vitro.
    Dalvi PS; Belsham DD
    Endocrinology; 2012 May; 153(5):2385-97. PubMed ID: 22416082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.
    Henderson SJ; Konkar A; Hornigold DC; Trevaskis JL; Jackson R; Fritsch Fredin M; Jansson-Löfmark R; Naylor J; Rossi A; Bednarek MA; Bhagroo N; Salari H; Will S; Oldham S; Hansen G; Feigh M; Klein T; Grimsby J; Maguire S; Jermutus L; Rondinone CM; Coghlan MP
    Diabetes Obes Metab; 2016 Dec; 18(12):1176-1190. PubMed ID: 27377054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of feed restriction and supplemental dietary fat on gut peptide and hypothalamic neuropeptide messenger ribonucleic acid concentrations in growing wethers.
    Relling AE; Pate JL; Reynolds CK; Loerch SC
    J Anim Sci; 2010 Feb; 88(2):737-48. PubMed ID: 19897637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
    Chelikani PK; Haver AC; Reidelberger RD
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.